It is primarily used to treat vitamin B12 deficiency, which can lead to anemia, fatigue, and neurological symptoms
Adjust based on thirst, urine color, and activity level
Protocol approach 3: comprehensive repair (thymosin alpha-1 plus BPC-157 plus TB-500) Goal: Immune rebalancing combined with aggressive tissue repair Components: Thymosin alpha-1: 1.6 mg subcutaneously twice per week BPC-157: 250 mcg subcutaneously twice daily near affected tissue TB-500 : 2-5 mg subcutaneously twice per week for loading, then weekly for maintenance Rationale: This three-peptide approach targets immune regulation (TA1), mucosal and tissue healing (BPC-157), and cellular migration plus repair (TB-500)
Repeated injection in the same exact spot causes lipohypertrophy, a thickening of the subcutaneous fat tissue that creates permanent or semi-permanent bumps
Typical dosing is 0.2ml administered in the evening, on an empty stomach, five out of seven days of the week
